- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice
Search this article
Description
Pigment epithelium-derived factor (PEDF) has been shown to be a potent inhibitor of inflammation through its anti-oxidative property. Since oxidative response is considered to play the pivotal role of the development and progression of nonalcoholic steatohepatitis (NASH), it is conceivable that PEDF may play a protective role against NASH. In this study, we examined whether administration of PEDF slowed the progression of NASH in mice models.Mice were fed methionine- and choline-deficient (MCD) diet with or without intramuscular administration of adenovirus-expressing PEDF (Ad-PEDF). Effects of PEDF administration on NASH were histologically and biochemically evaluated.Administration of Ad-PEDF significantly decreased hepatic fat storage as well as serum levels of ALT in MCD diet-fed mice. Dihydroethidium staining showed that MCD diet-triggered oxidative stress was reduced in the liver of Ad-PEDF-administered mice compared to that of PBS- or Ad-LacZ-administered mice. Activation of Kupffer cells and hepatic fibrosis was also inhibited by Ad-PEDF administration. Quantitative real-time RT-PCR revealed that MCD diet up-regulated expressions of TNF-α, IL-1β, IL-6, TGF-β, collagen-1, and collagen-3 mRNA, which were also attenuated with Ad-PEDF administration, whereas MCD diet-induced down-regulation of expressions of PPAR-γ mRNA was restored with Ad-PEDF administration. Furthermore, immunoblotting analysis showed that MCD diet-induced up-regulation of NADPH oxidase components was significantly decreased in Ad-PEDF-administered mice.The present results demonstrated for the first time that PEDF could slow the development and progression of steatohepatitis through the suppression of steatosis and inflammatory response in MCD diet-fed mice. Our study suggests that PEDF supplementation may be a novel therapeutic strategy for the treatment of NASH.
Journal
-
- Digestive Diseases and Sciences
-
Digestive Diseases and Sciences 62 (6), 1527-1536, 2017-04-01
Springer Science and Business Media LLC
- Tweet
Keywords
- Liver Cirrhosis
- Male
- Kupffer Cells
- Interleukin-1beta
- Down-Regulation
- Injections, Intramuscular
- Collagen Type I
- Adenoviridae
- Mice
- Methionine
- Animals
- Protease Inhibitors
- Nerve Growth Factors
- RNA, Messenger
- Eye Proteins
- Serpins
- Interleukin-6
- Tumor Necrosis Factor-alpha
- NADPH Oxidases
- Alanine Transaminase
- Choline Deficiency
- Diet
- Up-Regulation
- Fatty Liver
- Mice, Inbred C57BL
- PPAR gamma
- Disease Models, Animal
- Oxidative Stress
- Collagen Type III
- Adipose Tissue
Details 詳細情報について
-
- CRID
- 1360846640305452928
-
- ISSN
- 15732568
- 01632116
-
- PubMed
- 28365916
-
- Article Type
- journal article
-
- Data Source
-
- Crossref
- KAKEN
- OpenAIRE